This company listing is no longer active
Jilin Zixin Pharmaceutical IndustrialLtd Balance Sheet Health
Financial Health criteria checks 3/6
Jilin Zixin Pharmaceutical IndustrialLtd has a total shareholder equity of CN¥1.4B and total debt of CN¥6.8B, which brings its debt-to-equity ratio to 497.1%. Its total assets and total liabilities are CN¥10.2B and CN¥8.9B respectively.
Key information
497.1%
Debt to equity ratio
CN¥6.77b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥15.31m |
| Equity | CN¥1.36b |
| Total liabilities | CN¥8.85b |
| Total assets | CN¥10.22b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002118's short term assets (CN¥8.0B) exceed its short term liabilities (CN¥7.8B).
Long Term Liabilities: 002118's short term assets (CN¥8.0B) exceed its long term liabilities (CN¥1.0B).
Debt to Equity History and Analysis
Debt Level: 002118's net debt to equity ratio (496%) is considered high.
Reducing Debt: 002118's debt to equity ratio has increased from 90% to 497.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 002118 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 002118 has less than a year of cash runway if free cash flow continues to grow at historical rates of 25.7% each year.